Quick Answer
CUMBERLAND PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 14.96 million shares for the year ending 2025.
- CUMBERLAND PHARMACEUTICALS INC showed an increase of +7.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from CUMBERLAND PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), CUMBERLAND PHARMACEUTICALS INC's Common Stock Shares Outstanding has declined by 26.5%.
- Historical annual values: Fiscal year 2025: 14.96 million shares | Fiscal year 2024: 13.95 million shares | Fiscal year 2023: 14.12 million shares | Fiscal year 2022: 14.37 million shares | Fiscal year 2021: 14.74 million shares | Fiscal year 2020: 14.99 million shares | Fiscal year 2019: 15.26 million shares | Fiscal year 2018: 15.48 million shares | Fiscal year 2017: 16.07 million shares | Fiscal year 2016: 16.07 million shares | Fiscal year 2015: 16.38 million shares | Fiscal year 2014: 17.12 million shares | Fiscal year 2013: 17.99 million shares | Fiscal year 2012: 18.94 million shares | Fiscal year 2011: 20.02 million shares | Fiscal year 2010: 20.34 million shares.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: